Penumbra, Inc.
PEN
Rank in Stocks
#1683
Penumbra, Inc., together with its subsidiaries, designs, develops,... Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Share Price
$322.77
Market Cap
$12.71B
Change (1 day)
0.57%
Change (1 year)
29.63%
Country
US
Trade Penumbra, Inc. (PEN)
Category
Healthcare
Number of shares outstanding for Penumbra, Inc. (PEN)
Number of shares outstanding as of June 2026: 39.31M
According to Penumbra, Inc. latest financial reports and stock price the company's current number of shares outstanding is 39.31M. At the end of December 2023 the company had 38.40M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Penumbra, Inc. (PEN) from 2012 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 39.31M | 1.76% |
| 2024 | 38.63M | 0.61% |
| 2023 | 38.40M | 1.48% |
| 2022 | 37.84M | 2.93% |
| 2021 | 36.76M | 2.79% |
| 2020 | 35.77M | 2.92% |
| 2019 | 34.75M | -3.70% |
| 2018 | 36.09M | 9.43% |
| 2017 | 32.98M | 8.25% |
| 2016 | 30.46M | 154.01% |
| 2015 | 11.99M | -51.07% |
| 2014 | 24.51M | 0.00% |
| 2013 | 24.51M | 0.00% |
| 2012 | 24.51M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 1.74B | 4,333.56% |
US
|
|
| 1.28B | 3,161.10% |
IE
|
|
| 383.50M | 875.46% |
US
|
|
| 1.48B | 3,658.37% |
US
|
|
| - | - |
DE
|
